查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1742833

全球急性肾损伤治疗市场

Acute Kidney Injury Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 366 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球急性肾损伤治疗市场规模将达到 25 亿美元

全球急性肾损伤治疗市场规模预计在2024年达到18亿美元，预计在2024-2030年的分析期内将以5.9%的复合年增长率增长，到2030年将达到25亿美元。肾前性急性肾损伤治疗是本报告分析的细分市场之一，预计其复合年增长率为5.2%，到分析期结束时规模将达到14亿美元。肾内性急性肾损伤治疗细分市场在分析期间的复合年增长率预计为6.7%。

美国市场规模估计为 4.784 亿美元，而中国市场预计复合年增长率为 9.2%

美国急性肾损伤治疗市场规模预计2024年达到4.784亿美元。作为世界第二大经济体，中国预计在2030年市场规模将达到4.995亿美元，在分析期间（2024-2030年）的复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.0%和5.8%。在欧洲，预计德国的复合年增长率为3.8%。

全球急性肾损伤 (AKI) 治疗市场 - 主要趋势和驱动因素摘要

为什么急性肾衰竭成为多重系统护理和重症患者监护的重要焦点？

急性肾损伤 (AKI) 是指肾功能突然且通常可逆性的衰竭，它日益被认为是住院和重症患者的严重併发症。 AKI 通常由败血症、脱水、药物中毒或缺血诱发，并伴随高发病率、高死亡率和延长住院时间。 AKI 的发生率不断上升，尤其是在老龄化人口和加护治疗环境中，这推动了对及时诊断、支持性干预和专业治疗策略的需求。

由于 AKI 通常是慢性肾臟病(CKD) 和多重器官衰竭的前兆，因此早期发现和早期疗育对于保护肾功能和提高生存率至关重要，这使得 AKI 治疗成为肾臟病学、急诊医学和重症监护综合护理途径的关键组成部分。

治疗方法和肾臟支持技术如何发展以实现有效的 AKI 管理？

目前的治疗模式着重于支持性治疗，包括稳定血流动力学、维持体液和电解质平衡以及停用肾毒性药物。肾臟替代疗法 (RRT)——间歇性血液透析机、连续性肾臟替代疗法 (CRRT) 和腹膜透析——用于重症和难治性病例。 CRRT 因其较温和的液体管理及血流动力学相容性，尤其在 ICU 中备受青睐。

药物研究正在探索旨在减轻缺血性损伤、发炎和氧化压力的肾臟保护药物。 NGAL、KIM-1和Cystatin C等诊断性生物标记正被纳入风险分层方案，从而实现更早的治疗性介入。透析设备、生物相容性膜和自动化液体管理系统的创新，进一步提高了急性肾损伤（AKI）治疗的精确度和病人安全性。

病患小组和医疗保健环境正在推动对 AKI 治疗的需求？

AKI 常见于老年患者、ICU 患者、败血症患者以及接受大型手术或显影剂显影剂的患者。由于暴露于肾毒性治疗方案，AKI 在肿瘤科、心臟科和移植医学领域也较为常见。医院和加护病房是 AKI 的主要治疗场所，其次是肾臟病诊所和急性復健中心，用于追踪和肾功能监测。

北美和欧洲占据相当大的市场占有率，这得益于先进的医院基础设施、高度的认知度以及完善的重症加护体系。亚太地区由于人口结构变化、ICU容量增加以及抗生素滥用和感染疾病负担等风险因素的增加，AKI发生率正在上升。新兴国家正透过培训临床医生和采购设备等方式逐步投入AKI应对措施。

政策倡议、技术整合和风险管理如何影响市场扩张？

医疗机构正透过临床指引、风险评估通讯协定和医院警报系统，优先进行急性肾损伤 (AKI) 的预防和早期疗育。 KDIGO 等组织正在进行标准化工作，推广液体管理、药物监测和肾臟辅助性治疗的最佳实践，而整合 EHR 的 AKI 警报系统则有助于即时检测和临床决策。

基于价值的护理模式和捆绑支付系统正在推动对早期急性肾损伤 (AKI)筛检和避免透析的投资。医院越来越多地采用数位化工具进行肾功能监测，研发机构也正在与产业界合作，加速生物标记和候选药物的开发。这些多学科合作正在提高临床对 AKI 的认识，并促进肾臟护理服务的系统性改进。

哪些因素将推动 AKI 治疗市场的成长？

由于高风险族群发病率上升、重症加护能力提升以及肾臟支持技术的应用日益普及，AKI 治疗市场正在蓬勃发展。关键驱动因素包括临床紧迫性、治疗指南的不断演变、CRRT 平台的创新以及诊断技术与急性护理工作流程的深度整合。随着医疗保健系统将维护多种疾病患者的肾功能置于优先地位，AKI 治疗正逐渐成为医院护理的核心组成部分。

展望未来，市场动能将取决于相关人员如何有效地扩大早期检测、制定干预措施并遏制慢性肾臟併发症的进展。随着肾臟健康成为多重器官疾病管理的核心，急性肾损伤治疗很可能成为改变加护治疗和预防护理途径结果的策略槓桿。

部分

类型（肾前性、原发性、肾后性）、治疗（治疗方法、药物）、分销管道（医院药房、零售药房、网路药房）

受访公司范例（值得关注的36家公司）

  • AbbVie Inc.
  • Amanta Healthcare
  • Amgen Inc.
  • AM-Pharma BV
  • Angion Biomedica Corp.
  • Arch Biopartners Inc.
  • Asahi Kasei Medical Co., Ltd.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • CalciMedica, Inc.
  • Eli Lilly and Company
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Guard Therapeutics AB
  • ICU Medical, Inc.
  • Kringle Pharma, Inc.
  • LG Chem Ltd.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP34543

Global Acute Kidney Injury Treatment Market to Reach US$2.5 Billion by 2030

The global market for Acute Kidney Injury Treatment estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Prerenal Acute Kidney Injury Treatment, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Intrinsic Renal Acute Kidney Injury Treatment segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$478.4 Million While China is Forecast to Grow at 9.2% CAGR

The Acute Kidney Injury Treatment market in the U.S. is estimated at US$478.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$499.5 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Acute Kidney Injury (AKI) Treatment Market - Key Trends & Drivers Summarized

Why Is Acute Kidney Injury Emerging as a Critical Focus in Multisystem Care and Critical Illness Management?

Acute Kidney Injury (AKI)-a sudden and often reversible decline in renal function-is increasingly recognized as a serious complication in hospitalized and critically ill patients. Commonly triggered by sepsis, dehydration, drug toxicity, or ischemia, AKI is associated with high morbidity, mortality, and extended hospital stays. Its growing prevalence, particularly in aging populations and intensive care settings, is driving demand for timely diagnosis, supportive interventions, and specialized treatment strategies.

With AKI often serving as a precursor to chronic kidney disease (CKD) or multi-organ failure, early recognition and intervention have become central to preserving renal function and improving survival rates. This has made AKI treatment an essential component of integrated care pathways in nephrology, emergency medicine, and critical care.

How Are Therapeutic Approaches and Renal Support Technologies Evolving for Effective AKI Management?

Current treatment paradigms focus on supportive care, including hemodynamic stabilization, fluid and electrolyte balance, and withdrawal of nephrotoxic agents. Renal replacement therapy (RRT)-through intermittent hemodialysis, continuous renal replacement therapy (CRRT), or peritoneal dialysis-is used in severe or refractory cases. CRRT, in particular, is gaining traction in ICU settings due to its gentler fluid management and hemodynamic compatibility.

Pharmaceutical research is exploring renoprotective agents aimed at mitigating ischemic damage, inflammation, and oxidative stress. Biomarker-driven diagnostics-such as NGAL, KIM-1, and cystatin C-are being incorporated into risk stratification protocols, enabling earlier therapeutic intervention. Innovations in dialysis machines, biocompatible membranes, and automated fluid management systems are further enhancing treatment precision and patient safety in AKI care.

Which Patient Groups and Healthcare Settings Are Driving AKI Treatment Demand?

AKI frequently affects elderly individuals, ICU patients, individuals with sepsis, and those undergoing major surgery or receiving contrast agents. It is also prevalent in oncology, cardiology, and transplant care due to exposure to nephrotoxic regimens. Hospitals and intensive care units are the primary treatment environments, followed by nephrology clinics and post-acute rehabilitation centers for follow-up and renal function monitoring.

North America and Europe account for significant market share, supported by advanced hospital infrastructure, high awareness, and comprehensive critical care frameworks. Asia-Pacific is witnessing increasing incidence due to demographic transitions, growing ICU capacity, and rising exposure to risk factors such as antibiotic overuse and infectious disease burden. Emerging economies are gradually investing in AKI preparedness through clinician training and equipment procurement.

How Are Policy Initiatives, Technological Integration, and Risk Management Practices Shaping Market Expansion?

Health authorities are prioritizing AKI prevention and early intervention through clinical guidelines, risk assessment protocols, and hospital-based alert systems. Standardization efforts from bodies such as KDIGO (Kidney Disease: Improving Global Outcomes) are promoting best practices in fluid management, drug monitoring, and renal support therapy. Meanwhile, EHR-integrated AKI alert systems are aiding real-time detection and clinical decision-making.

Value-based care models and bundled payment systems are driving investments in early AKI screening and avoidance of dialysis initiation. Hospitals are increasingly adopting digital tools for kidney function surveillance, while research institutions are collaborating with industry to accelerate biomarker development and novel drug candidates. These cross-sector efforts are raising the clinical profile of AKI and catalyzing systemic improvements in renal care delivery.

What Are the Factors Driving Growth in the AKI Treatment Market?

The AKI treatment market is growing in response to rising incidence in high-risk populations, expanding critical care capacity, and increasing adoption of renal support technologies. Key drivers include clinical urgency, evolving treatment guidelines, innovation in CRRT platforms, and deeper integration of diagnostics into acute care workflows. As health systems prioritize kidney function preservation across a range of conditions, AKI treatment is becoming a core focus of hospital-based care.

Looking ahead, market momentum will depend on how effectively stakeholders can scale early detection, tailor interventions, and reduce progression to chronic kidney complications. As kidney health becomes central to managing multisystem diseases, could acute kidney injury treatment emerge as a strategic lever in transforming outcomes across intensive and preventive care pathways?

SCOPE OF STUDY:

The report analyzes the Acute Kidney Injury Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury); Treatment (Therapy, Drugs); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AbbVie Inc.
  • Amanta Healthcare
  • Amgen Inc.
  • AM-Pharma B.V.
  • Angion Biomedica Corp.
  • Arch Biopartners Inc.
  • Asahi Kasei Medical Co., Ltd.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • CalciMedica, Inc.
  • Eli Lilly and Company
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Guard Therapeutics AB
  • ICU Medical, Inc.
  • Kringle Pharma, Inc.
  • LG Chem Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Acute Kidney Injury Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Hospitalization Rates for Critical Illnesses Throw the Spotlight on Acute Kidney Injury (AKI) Treatment Needs
    • Increasing Incidence of Sepsis and Cardiovascular Complications Spurs AKI Diagnosis and Intervention Demand
    • Advancements in Renal Biomarkers Strengthen the Business Case for Early AKI Detection and Treatment
    • Growing Use of Continuous Renal Replacement Therapy (CRRT) Drives Equipment and Consumable Adoption
    • Integration of AI-Based Predictive Tools in ICU Settings Bodes Well for Early AKI Risk Assessment
    • Rising Availability of Portable Dialysis Machines Expands Access to AKI Management in Non-Traditional Settings
    • Higher Adoption of EHR and Data Analytics Enhances AKI Monitoring and Decision-Making in Critical Care
    • Growth in Pediatric and Geriatric AKI Cases Sets the Stage for Demographic-Specific Treatment Protocols
    • Emergence of Biocompatible Dialysis Filters Enhances Patient Safety and Therapy Tolerance in AKI Treatment
    • Rising Focus on Post-AKI Recovery and Long-Term Kidney Function Preservation Drives Innovation in Follow-Up Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Acute Kidney Injury Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Acute Kidney Injury Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Prerenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Prerenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intrinsic Renal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intrinsic Renal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Postrenal Acute Kidney Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Postrenal Acute Kidney Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • JAPAN
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CHINA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • EUROPE
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Acute Kidney Injury Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • FRANCE
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • GERMANY
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • INDIA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Acute Kidney Injury Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Acute Kidney Injury Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AFRICA
    • Acute Kidney Injury Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Acute Kidney Injury Treatment by Type - Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Type - Percentage Breakdown of Value Sales for Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury and Postrenal Acute Kidney Injury for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Acute Kidney Injury Treatment by Treatment - Therapy and Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Treatment - Percentage Breakdown of Value Sales for Therapy and Drugs for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Acute Kidney Injury Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Acute Kidney Injury Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION